Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Keywords: | Australia; Bruton tyrosine kinase (BTK) inhibitors; chronic lymphocytic leukaemia; ibrutinib; proton pump inhibitor (PPI); real-world evidence; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Proton Pump Inhibitors; Neoplasm Recurrence, Local; Australia; Protein Kinase Inhibitors |
| Dates: |
|
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Clinical Dentistry (Sheffield) |
| Depositing User: | Symplectic Sheffield |
| Date Deposited: | 19 Jan 2024 11:52 |
| Last Modified: | 19 Jan 2024 11:52 |
| Status: | Published |
| Publisher: | Wiley |
| Refereed: | Yes |
| Identification Number: | 10.1111/imj.16267 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:207961 |
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)